Pharmacological effect of aminoferrocene in mice with L1210 leukemia

Aim: To study the cytostatic and some biological effects of aminoferrocene using mice with L1210 lymphoid leukemia. Materials and Methods: Experiments were performed on BDF1 male mice (DBA/2, female × C57Bl/6, male) with transplantable L1210 lymphoid leukemia. Determination of antitumor activity of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2015
Hauptverfasser: Chekhun, V.F., Mokhir, A., Daum, S., Todor, I.N., Lukianova, N.Yu., Shvets, Yu.V., Burlaka, A.P.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2015
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/145467
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Pharmacological effect of aminoferrocene in mice with L1210 leukemia / V.F. Chekhun, A. Mokhir, S. Daum, I.N. Todor, N.Yu. Lukianova, Yu.V. Shvets, A.P. Burlaka // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 120-125. — Бібліогр.: 34 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-145467
record_format dspace
spelling Chekhun, V.F.
Mokhir, A.
Daum, S.
Todor, I.N.
Lukianova, N.Yu.
Shvets, Yu.V.
Burlaka, A.P.
2019-01-22T11:33:40Z
2019-01-22T11:33:40Z
2015
Pharmacological effect of aminoferrocene in mice with L1210 leukemia / V.F. Chekhun, A. Mokhir, S. Daum, I.N. Todor, N.Yu. Lukianova, Yu.V. Shvets, A.P. Burlaka // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 120-125. — Бібліогр.: 34 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145467
Aim: To study the cytostatic and some biological effects of aminoferrocene using mice with L1210 lymphoid leukemia. Materials and Methods: Experiments were performed on BDF1 male mice (DBA/2, female × C57Bl/6, male) with transplantable L1210 lymphoid leukemia. Determination of antitumor activity of Benzyl-Fc Boron (Bn), it was injected intraperitoneally 6 times daily, starting on day 2 after L1210 leukemia cell transplantation. Doses of Bn such as 26; 260 and 2600 μg/kg were used. The determination of intracellular content of cardiolipin, thiols, reactive oxygen species (ROS) and also analysis of Annexin V positivity and mitochondrial transmembrane potential (JC-1 staining) were performed with use of flow cytometry. The levels of “free iron” complexes, transferrin active forms and the rate of NO generation were measured by EPR-specroscopy. Results: Six daily injections of Bn at a dose of 26 μg/kg resulted in an increased survival of mice with L1210 leukemia by 28% (p < 0.05). Bn led to an increase of apoptotic cells number and ROS amount in leukemia cells. Besides, Bn caused a decrease of cardiolipin and nonprotein thiol compounds content. The membrane electrochemical potential of cell mitochondria was decreased also after Bn administration. Studies using EPR-spectroscopy revealed a significant increase in a level of “free iron”, content of transferrin active species and generation rate of NO by inducible NO-synthase in L1210 cells after aminoferrocene administration. Conclusion: Our data indicate that Benzyl-Fc Boron can be promising candidate for realizing a new strategy of anticancer therapy with the use of ROS-inducing agents. Key Words: aminoferrocene, tumor, L1210 leukemia, mitochondria membrane electrochemical potential, cardiolipin, thiols, ROS, transferrin, NO-generation.
This work was supported by: 1. German Research Council (DFG), project № MO 1418/7–1 “Aminoferrocene dendrimers as prodrugs for the therapy of hematologic cancers derived from B-cells”. 2. State Aim Scientific-Technical Programme of Ukraine “Nanotechnology and nanomaterials” (Project № 5.18.3.53 “Biological activity and safety of nanomaterials which can be use for development of antitumor drugs vector systems”). 3. Aim Complex Programme of Fundamental Investigations of NAS of Ukraine (Project № 96/14-H “Interaction of nanostructural materials with normal and tumor cells, development of delivery methods, safety of their use”).
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Pharmacological effect of aminoferrocene in mice with L1210 leukemia
spellingShingle Pharmacological effect of aminoferrocene in mice with L1210 leukemia
Chekhun, V.F.
Mokhir, A.
Daum, S.
Todor, I.N.
Lukianova, N.Yu.
Shvets, Yu.V.
Burlaka, A.P.
Original contributions
title_short Pharmacological effect of aminoferrocene in mice with L1210 leukemia
title_full Pharmacological effect of aminoferrocene in mice with L1210 leukemia
title_fullStr Pharmacological effect of aminoferrocene in mice with L1210 leukemia
title_full_unstemmed Pharmacological effect of aminoferrocene in mice with L1210 leukemia
title_sort pharmacological effect of aminoferrocene in mice with l1210 leukemia
author Chekhun, V.F.
Mokhir, A.
Daum, S.
Todor, I.N.
Lukianova, N.Yu.
Shvets, Yu.V.
Burlaka, A.P.
author_facet Chekhun, V.F.
Mokhir, A.
Daum, S.
Todor, I.N.
Lukianova, N.Yu.
Shvets, Yu.V.
Burlaka, A.P.
topic Original contributions
topic_facet Original contributions
publishDate 2015
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Aim: To study the cytostatic and some biological effects of aminoferrocene using mice with L1210 lymphoid leukemia. Materials and Methods: Experiments were performed on BDF1 male mice (DBA/2, female × C57Bl/6, male) with transplantable L1210 lymphoid leukemia. Determination of antitumor activity of Benzyl-Fc Boron (Bn), it was injected intraperitoneally 6 times daily, starting on day 2 after L1210 leukemia cell transplantation. Doses of Bn such as 26; 260 and 2600 μg/kg were used. The determination of intracellular content of cardiolipin, thiols, reactive oxygen species (ROS) and also analysis of Annexin V positivity and mitochondrial transmembrane potential (JC-1 staining) were performed with use of flow cytometry. The levels of “free iron” complexes, transferrin active forms and the rate of NO generation were measured by EPR-specroscopy. Results: Six daily injections of Bn at a dose of 26 μg/kg resulted in an increased survival of mice with L1210 leukemia by 28% (p < 0.05). Bn led to an increase of apoptotic cells number and ROS amount in leukemia cells. Besides, Bn caused a decrease of cardiolipin and nonprotein thiol compounds content. The membrane electrochemical potential of cell mitochondria was decreased also after Bn administration. Studies using EPR-spectroscopy revealed a significant increase in a level of “free iron”, content of transferrin active species and generation rate of NO by inducible NO-synthase in L1210 cells after aminoferrocene administration. Conclusion: Our data indicate that Benzyl-Fc Boron can be promising candidate for realizing a new strategy of anticancer therapy with the use of ROS-inducing agents. Key Words: aminoferrocene, tumor, L1210 leukemia, mitochondria membrane electrochemical potential, cardiolipin, thiols, ROS, transferrin, NO-generation.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/145467
citation_txt Pharmacological effect of aminoferrocene in mice with L1210 leukemia / V.F. Chekhun, A. Mokhir, S. Daum, I.N. Todor, N.Yu. Lukianova, Yu.V. Shvets, A.P. Burlaka // Experimental Oncology. — 2015. — Т. 37, № 2. — С. 120-125. — Бібліогр.: 34 назв. — англ.
work_keys_str_mv AT chekhunvf pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT mokhira pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT daums pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT todorin pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT lukianovanyu pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT shvetsyuv pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
AT burlakaap pharmacologicaleffectofaminoferroceneinmicewithl1210leukemia
first_indexed 2025-12-01T01:56:03Z
last_indexed 2025-12-01T01:56:03Z
_version_ 1850859042496315392